This is a routine update on an existing buyback program. No immediate trading signal. Monitor for any acceleration or change in the pace of repurchases, but the program is proceeding as planned.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 6 $49.26entry
- T+1 · 4mo ago +0.77%α +1.25% · $49.64
- T+5 · 4mo ago +0.45%α −0.04% · $49.48
- T+20 · 3mo ago −4.43%α −3.86% · $47.08
- T+60 · 5w ago −22.23%α −24.14% · $38.31
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Novo Nordisk filed a routine 6-K update on its ongoing B share repurchase program, reporting weekly transactions from June 29 to July 3, 2026. The company has repurchased 23,009,179 B shares since February 4, 2026, for a total of DKK 6.22 billion, representing 0.9% of share capital. This is a standard periodic disclosure with no new material information.
Key Facts
- Novo Nordisk repurchased 1,000,000 B shares from June 29 to July 3, 2026, at an average price of DKK 320.93 per share, totaling DKK 320.93 million.
- Since February 4, 2026, the company has repurchased 23,009,179 B shares at an average price of DKK 270.32, for a total transaction value of DKK 6,219,775,971.
- The buyback is part of a program of up to DKK 15 billion over 12 months beginning February 4, 2026.
- As of July 3, 2026, Novo Nordisk holds 40,194,480 B shares as treasury shares, corresponding to 0.9% of total share capital.
Financial Impact
No new financial impact; the buyback is ongoing and previously announced. Total committed repurchase amount is up to DKK 15 billion, with DKK 6.22 billion executed to date.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-004469 |
| Document: 0001171843-26-004469-index-headers.html | 0001171843-26-004469 |
| Document: 0001171843-26-004469-index.html | 0001171843-26-004469 |
| Document: 0001171843-26-004469.txt | 0001171843-26-004469 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 4, 2026 today | 6-K | $42.95 | awaiting T+20 | awaiting T+20 | $42.18 (−1.79%) |
Nov 3, 2026 1d ago | 6-K | $40.19 | awaiting T+20 | awaiting T+20 | $42.18 (+4.95%) |
Oct 26, 2026 9d ago | 6-K | $39.13 | awaiting T+20 | awaiting T+20 | $42.18 (+7.79%) |
Oct 26, 2026 10d ago | Court Ruling | $38.67 | awaiting T+20 | awaiting T+20 | $42.18 (+9.08%) |
Oct 19, 2026 16d ago | 6-K | $38.42 | awaiting T+20 | awaiting T+20 | $42.18 (+9.79%) |
Oct 13, 2026 22d ago | 6-K | $38.06 | awaiting T+20 | awaiting T+20 | $42.18 (+10.83%) |
Oct 6, 2026 29d ago | 6-K | $37.53 $40.19 | ▲ +7.09% | ▲ +10.26% | $42.18 (+12.39%) |
Sep 28, 2026 5w ago | 6-K | $38.71 $38.95 | ▲ +0.61% | ▲ +0.64% | $42.18 (+8.96%) |
Sep 23, 2026 6w ago | Court Ruling | $38.62 $39.43 | ▲ +2.10% | ▲ +2.52% | $42.18 (+9.22%) |
Sep 21, 2026 6w ago | 6-K | $39.80 $38.42 | ▼ −3.47% | ▼ −2.56% | $42.18 (+5.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers